We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,426 results
  1. Improved Aerosolization Stability of Inhalable Tobramycin Powder Formulation by Co-Spray Drying with Colistin

    Purpose

    Tobramycin shows synergistic antibacterial activity with colistin and can reduce the toxic effects of colistin. The purpose of this study is...

    Vaibhav Pathak, Heejun Park, ... Qi Tony Zhou in Pharmaceutical Research
    Article 02 August 2022
  2. Risk Factors Associated with Suboptimal Tobramycin Levels in the Medical Intensive Care Unit

    Background

    Optimal aminoglycoside dosing in critically ill patients represents a challenge for practitioners, especially in the medical intensive care...

    Jacob P. Counts, Jessica L. Elefritz, ... Julia J. Beatty in European Journal of Drug Metabolism and Pharmacokinetics
    Article 14 January 2022
  3. Tobramycin-loaded complexes to prevent and disrupt Pseudomonas aeruginosa biofilms

    Carbohydrate-based materials are increasingly investigated for a range of applications spanning from healthcare to advanced functional materials....

    Delia Boffoli, Federica Bellato, ... Francesca Mastrotto in Drug Delivery and Translational Research
    Article 28 November 2021
  4. Tazobactam/ceftolozane and tobramycin combination therapy in extensively drug-resistant Pseudomonas aeruginosa infections in severe burn injury: a case report

    Background

    Combination therapy with tazobactam/ceftolozane (TAZ/CTLZ) and high-dose aminoglycosides has been reported to be efficacious in extensively...

    Yuta Ibe, Ryuichiro Kakizaki, ... Masahide Fukudo in Journal of Pharmaceutical Health Care and Sciences
    Article Open access 08 August 2023
  5. In vitro models to detect in vivo bile acid changes induced by antibiotics

    Bile acid homeostasis plays an important role in many biological activities through the bile–liver–gut axis. In this study, two in vitro models were...

    Nina Zhang, **gxuan Wang, ... Ivonne M. C. M. Rietjens in Archives of Toxicology
    Article Open access 08 September 2022
  6. Elution Profiles of Synthetic CaSO4 Hemihydrate Beads Loaded with Vancomycin and Tobramycin

    Backgrounds and Objectives

    The use of local antibiotic delivery vehicles is common in the management of biofilm-related infections as they provide...

    Gerhard E. Maale, John J. Eager, ... Flavio A. Calderon II in European Journal of Drug Metabolism and Pharmacokinetics
    Article Open access 23 April 2020
  7. Does Sample Size, Sampling Strategy, or Handling of Concentrations Below the Lower Limit of Quantification Matter When Externally Evaluating Population Pharmacokinetic Models?

    Background and Objectives

    Precision dosing requires selecting the appropriate population pharmacokinetic model, which can be assessed through external...

    Mehdi El Hassani, Uwe Liebchen, Amélie Marsot in European Journal of Drug Metabolism and Pharmacokinetics
    Article 05 May 2024
  8. Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates

    Background

    Biofilms play a role in recalcitrance and treatability of bacterial infections, but majority of known antibiotic resistance mechanisms are...

    Fereshteh Jabalameli, Mohammad Emaneini, ... Maryam Siroosi in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 20 July 2023
  9. Screening, Post-SELEX Optimization and Application of DNA Aptamers Specific for Tobramycin

    Tobramycin (TOB) is an aminoglycoside antibiotic. The residue of TOB in animal-derived foods and environment will be harmful to human health, and...
    Nandi Zhou, Rongfeng Cai, Xuyan Han in Genotype Phenotype Coupling
    Protocol 2020
  10. Near Elimination of In Vitro Predicted Extrathoracic Aerosol Deposition in Children Using a Spray-Dried Antibiotic Formulation and Pediatric Air-Jet DPI

    Purpose

    This study evaluated the in vitro aerosol performance of a dry powder antibiotic product that combined a highly dispersible tobramycin powder...

    Dale Farkas, Morgan L. Thomas, ... Worth Longest in Pharmaceutical Research
    Article 27 June 2022
  11. Aminoglycosides

    Aminoglycosides are derivatives of naturally occurring organisms, and several aminoglycosides have been introduced for clinical use since the...
    Robert W. Finberg, Roy Guharoy in Clinical Use of Anti-infective Agents
    Chapter 2021
  12. When will the Glomerular Filtration Rate in Former Preterm Neonates Catch up with Their Term Peers?

    Aims

    Whether and when glomerular filtration rate (GFR) in preterms catches up with term peers is unknown. This study aims to develop a GFR maturation...

    Yunjiao Wu, Karel Allegaert, ... Swantje Völler in Pharmaceutical Research
    Article Open access 12 March 2024
  13. Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018

    Background

    Antimicrobial resistance threatens the ability to successfully prevent and treat infections. While hospital benchmarks regarding...

    Wallis Rudnick, John Conly, ... Michelle Science in Antimicrobial Resistance & Infection Control
    Article Open access 18 April 2023
  14. Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Non-obese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study

    Purpose

    Tobramycin is an aminoglycoside antibiotic of which the 24 h exposure correlates with efficacy. Recently, we found that clearance of the...

    Cornelis Smit, Roeland E. Wasmann, ... Catherijne A. J. Knibbe in Pharmaceutical Research
    Article Open access 30 May 2019
  15. Clinical characteristics and drug susceptibility profiles of Mycobacterium abscessus complex infection at a medical school in Thailand

    Objectives

    This study investigated the differences in epidemiological and clinical data, and antimicrobial susceptibilities among different subspecies...

    Songkiat Sukmongkolchai, Suthidee Petsong, ... Suwatchareeporn Rotcheewaphan in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 21 September 2023
  16. Co-transfer of IncFII/IncFIB and IncFII plasmids mediated by IS26 facilitates the transmission of mcr-8.1 and tmexCD1-toprJ1

    Purpose

    This study aimed to characterise the whole-genome structure of two clinical Klebsiella pneumoniae strains co-harbouring mcr-8.1 and tmexCD1-toprJ1...

    Qian Wang, Meng Zhang, ... Yingying Hao in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 13 February 2024
  17. Monitoring of tobramycin serum concentrations in selected critically ill patients receiving selective decontamination of the digestive tract: a retrospective evaluation

    Introduction

    Selective decontamination of the digestive tract (SDD) is a strategy in mechanically ventilated patients to reduce mortality. Treatment...

    J. E. Möhlmann, M. van Luin, ... M. R. de Maat in European Journal of Clinical Pharmacology
    Article 18 February 2019
  18. LipNanoCar Technology – A Versatile and Scalable Technology for the Production of Lipid Nanoparticles

    The extensive knowledge in the miniemulsion technique used in biocatalysis applications by the authors allowed the development of drug delivery...
    Vera L. R. Esgueira, Clara P. A. Lopes, ... Luis P. Fonseca in Nanotoxicology in Safety Assessment of Nanomaterials
    Chapter 2022
  19. Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk

    Background

    Cystic fibrosis (CF) is a genetic disease characterized by multi-system dysfunction resulting in recurrent lung infections and progressive...

    Awatif M. Abuzgaia, Abdelbaset A. Elzagallaai, ... Michael J. Rieder in Molecular Diagnosis & Therapy
    Article 20 March 2023
  20. Defining the Importance of Age-Related Changes in Drug Clearance to Optimizing Aminoglycoside Dosing Regimens for Adult Patients with Cystic Fibrosis

    Background and Objective

    The number of adults living with cystic fibrosis (CF) has increased and will continue to do so with the approval of cystic...

    Roxane Rohani, Brian Hoff, ... Nathaniel J. Rhodes in European Journal of Drug Metabolism and Pharmacokinetics
    Article 09 December 2021
Did you find what you were looking for? Share feedback.